Ricardo Hosman Basto 🇨🇴🇦🇷🇮🇹 (@hosmanbasto) 's Twitter Profile
Ricardo Hosman Basto 🇨🇴🇦🇷🇮🇹

@hosmanbasto

Urologist, Renal & Prostatic Oncology, Minimally Invasive Surgery.

ID: 146704823

linkhttps://www.linkedin.com/in/ricardo-hosman-basto-ba5693138/ calendar_today22-05-2010 03:52:27

2,2K Tweet

264 Followers

660 Following

𝙍𝙞𝙘𝙘𝙖𝙧𝙙𝙤 𝘽𝙚𝙧𝙩𝙤𝙡𝙤 MD PhD (@ricbertolo) 's Twitter Profile Photo

Read our European Urology Oncology editorial: a paradigm shift is necessary to #reenvision the #perspective on #offclamp procedures. 🔗 Link to full text 👇🏼 authors.elsevier.com/c/1iSOX9Cfv-xp…

Read our <a href="/EurUrolOncol/">European Urology Oncology</a> editorial: 

a paradigm shift is necessary to #reenvision the #perspective on #offclamp procedures. 

🔗 Link to full text 👇🏼
authors.elsevier.com/c/1iSOX9Cfv-xp…
Javier Milei (@jmilei) 's Twitter Profile Photo

Hola @cfkargentina. Acabo de anular los aumentos de sueldo de todo el gabinete nacional. Ya que la vi tan preocupada por las jubilaciones ¿qué le parece si le anulo los $ 14.000.000 que cobra usted de jubilación de privilegio y le asigno una jubilación mínima? Estimo no va a

Ricardo Hosman Basto 🇨🇴🇦🇷🇮🇹 (@hosmanbasto) 's Twitter Profile Photo

Quiero agradecerles por su atención durante mi participación en la presentación, resalté la importancia del diagnóstico temprano y las opciones de tratamiento disponibles para esta condición. Agradezco al comité organizador Asociación de Medicos de Santa Marta por brindarme esta oportunidad.

Quiero agradecerles por su atención durante mi participación en la presentación, resalté la importancia del diagnóstico temprano y las opciones de tratamiento disponibles para esta condición. 

Agradezco al comité organizador <a href="/asomesasas/">Asociación de Medicos de Santa Marta</a> por brindarme esta oportunidad.
BJU International (@bjuijournal) 's Twitter Profile Photo

To Foley, or not to Foley, that is the question. Our European Section of Urolithiasis - EULIS & YAU ENDOUROLOGY collaboration article concludes that while Foley catheterization post-URS + DJ placement does not significantly improve biochemical outcomes, it may reduce postop pain doi.org/10.1111/bju.16…

To Foley, or not to Foley, that is the question.
Our <a href="/eulis_uroweb/">European Section of Urolithiasis - EULIS</a> &amp; <a href="/YAUEndourology/">YAU ENDOUROLOGY</a> collaboration article concludes that while Foley catheterization post-URS + DJ placement does not significantly improve biochemical outcomes, it may reduce postop pain doi.org/10.1111/bju.16…
BJU International (@bjuijournal) 's Twitter Profile Photo

Bladder sparing therapy, in carefully selected patients with BCG-unresponsive #BladderCancer, provides comparable survival in the intermediate term to upfront radical cystectomy. Jake Taylor, MD, MPH doi.org/10.1111/bju.16…

Bladder sparing therapy, in carefully selected patients with BCG-unresponsive #BladderCancer, provides comparable survival in the intermediate term to upfront radical cystectomy.
<a href="/doctorjakeuro/">Jake Taylor, MD, MPH</a>
doi.org/10.1111/bju.16…
Rashid K. Sayyid (@rksayyid) 's Twitter Profile Photo

PEACE-3: Ph 3 trial of 1L enza +/- Ra-223 in mCRPC pts w/bone mets (no visceral mets; doce/abi in mHSPC permitted; n=446) 🔹rPFS benefit: 19.4 vs 16.4 mo (HR: 0.69, p=0.0009) 🔹OS benefit: 42.3 vs 35 mo (HR: 0.69, p=0.0031) 🔹Delay in time to next systemic treatment (HR: 0.57,

PEACE-3: Ph 3 trial of 1L enza +/- Ra-223 in mCRPC pts w/bone mets (no visceral mets; doce/abi in mHSPC permitted; n=446)
🔹rPFS benefit: 19.4 vs 16.4 mo (HR: 0.69, p=0.0009)
🔹OS benefit: 42.3 vs 35 mo (HR: 0.69, p=0.0031)
🔹Delay in time to next systemic treatment (HR: 0.57,
Zach Klaassen (@zklaassen_md) 's Twitter Profile Photo

TiP - STAMPEDE2 177Lu-PSMA-617 Trial in new mHSPC UroToday.com MRC Clinical Trials Unit at UCL #ESMO24 🎯 n=1,756 ✏️1:1 to Arm A (SoC) vs Arm P (SoC + 177Lu-PSMA-617) - 177Lu-PSMA-617: 7.4 GBq on day 1 & day 8, 3x 6-weekly cycles ✏️Co-Prim EP: rPFS, OS ✏️Sec EP: FFS, PCSS, QoL, safety, tox, compliance,

TiP - STAMPEDE2 177Lu-PSMA-617 Trial in new mHSPC <a href="/urotoday/">UroToday.com</a> <a href="/MRCCTU/">MRC Clinical Trials Unit at UCL</a> #ESMO24 

🎯 n=1,756
✏️1:1 to Arm A (SoC) vs Arm P (SoC + 177Lu-PSMA-617)
- 177Lu-PSMA-617: 7.4 GBq on day 1 &amp; day 8, 3x 6-weekly cycles
✏️Co-Prim EP: rPFS, OS
✏️Sec EP: FFS, PCSS, QoL, safety, tox, compliance,
Zach Klaassen (@zklaassen_md) 's Twitter Profile Photo

⚡️ LBA ⚡️- ARANOTE: Efficacy & safety of Daro + ADT in mHSPC UroToday.com #ESMO24 Bayer Oncology Medical Daro + ADT vs PBO + ADT: 📌n=669; 446 Daro vs 223 PBO 📌Prim EP, rPFS: HR 0.54, 95% CI 0.41–0.71 📌OS: HR 0.81, 95% CI 0.59–1.12 📌TT CRPC: HR 0.40, 95% CI 0.32–0.51 📌TT PSA Prog: HR

⚡️ LBA ⚡️- ARANOTE: Efficacy &amp; safety of Daro + ADT in mHSPC  <a href="/urotoday/">UroToday.com</a> #ESMO24 <a href="/BayerOncMed/">Bayer Oncology Medical</a> 

Daro + ADT vs PBO + ADT:

📌n=669; 446 Daro vs  223 PBO
📌Prim EP, rPFS: HR 0.54, 95% CI 0.41–0.71
📌OS: HR 0.81, 95% CI 0.59–1.12
📌TT CRPC: HR 0.40, 95% CI 0.32–0.51
📌TT PSA Prog: HR
Daniel D Eun MD (@md_eun) 's Twitter Profile Photo

Robotic surgery can be so fun sometimes. Like when you get something really cool that’s really easy to fix. How about a large stone in a ureterocele while doing a prostatectomy? Endourological Society

UroToday.com (@urotoday) 's Twitter Profile Photo

Testosterone recovery following treatment suspension of enzalutamide + leuprolide or leuprolide alone in patients with high-risk biochemically recurrent prostate cancer: #EMBARK post-hoc analysis. Presented by Stephen Freedland, MD Cedars-Sinai. #AUA25 written coverage by Rashid K. Sayyid USC

Testosterone recovery following treatment suspension of enzalutamide + leuprolide or leuprolide alone in patients with high-risk biochemically recurrent prostate cancer: #EMBARK post-hoc analysis. Presented by <a href="/SFreedlandMD/">Stephen Freedland, MD</a> <a href="/CedarsSinai/">Cedars-Sinai</a>. #AUA25 written coverage by <a href="/RKSayyid/">Rashid K. Sayyid</a> <a href="/USC/">USC</a>
Stacy Loeb, MD (@loebstacy) 's Twitter Profile Photo

Top kidney cancer paper of the year at #suo25 - weight loss associated with lower risk of RCC. So happy to see lifestyle getting more attention! Maintaining a healthy body wt ➕ non-smoking, ⬆️ physical activity & 🚫red meat are modifiable ways to reduce RCC risk! #aua25

Top kidney cancer paper of the year at #suo25 - weight loss associated with lower risk of RCC. So happy to see lifestyle getting more attention! Maintaining a healthy body wt ➕ non-smoking, ⬆️ physical activity &amp; 🚫red meat are modifiable ways to reduce RCC risk! #aua25
European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

🧾 New Cheat Sheet on Prostate Cancer Treatment by Stage 🔹 Low-risk: Active surveillance; avoid ADT 🔹 Intermediate-risk: Surgery or RT; ADT case-based 🔹 High-risk: Surgery/RT + long-term ADT #EAUguidelines #ProstateCancer Download Cheat Sheet here: uroweb.org/guidelines/pro…

🧾 New Cheat Sheet on Prostate Cancer Treatment by Stage

🔹 Low-risk: Active surveillance; avoid ADT
🔹 Intermediate-risk: Surgery or RT; ADT case-based
🔹 High-risk: Surgery/RT + long-term ADT

#EAUguidelines #ProstateCancer

Download Cheat Sheet here:
uroweb.org/guidelines/pro…
European Association of Urology (EAU) (@uroweb) 's Twitter Profile Photo

🧾 Cheat Sheet on Follow-up for NMIBC 🔹 Risk-based surveillance 🔹 Lifelong follow-up for high-risk patients 🔹 Role of cytology & markers 🔍 No substitute for cystoscopy Download Cheat Sheet: uroweb.org/guidelines/non… #BladderCancer #NMIBC #EAUguidelines

🧾 Cheat Sheet on Follow-up for NMIBC

🔹 Risk-based surveillance
🔹 Lifelong follow-up for high-risk patients
🔹 Role of cytology &amp; markers
🔍 No substitute for cystoscopy

Download Cheat Sheet:
uroweb.org/guidelines/non…

#BladderCancer #NMIBC #EAUguidelines